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Abstract: Aquaporins (AQP) are family of water channels found in several epithelial and endothelial cells, whose recent 
identification has provided insights into water transport in several tissues, including the central nervous system (CNS). 
Since brain edema continues to be the main cause of death from several CNS diseases, such as stroke, much of the interest 
in AQPs and their functional contribution to the water balance is due to their possible role in clearing edema water from 
the brain and in managing hydrocephalus and benign intracranial hypertension, suggesting that they could be targets  
for future treatments of various brain conditions, particularly vascular diseases. AQPs also seem to be involved in cell  
migration, and a mechanism of AQP-facilitated cell migration has been proposed where local osmotic gradients created at 
the tip of the lamellipodium drive water influx, facilitating lamellipodial extension and cell migration. AQP-facilitated cell 
migration was also detected in tumour cells, suggesting that it may have an important role in tumour angiogenesis and 
spread, and accounting for AQP expression in many tumour cell types and for correlations found between AQP expression 
and tumour stage in some tumours. 
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1. INTRODUCTION 
  Aquaporins (AQP) are family of homologous water 
channels found in several epithelial and endothelial cell 
types involved in fluid transport. Expression of AQP1, 
AQP4 and AQP9 is found in the brain and in other tissues in 
the body. 
  AQP1 is strongly expressed in the majority of microvas-
cular endothelia outside the brain, as well as in endothelial 
cells in cornea, intestinal lacteals, renal proximal tubular 
epithelium, and other tissues [94, 98, 109]. Immunoreactivity 
for AQP1 has been detected in the capillary endothelium of 
pig ovary [87] and of rat parotid and submandibular gland 
[30], in the microvascular endothelia of mouse lungs and 
airways, and in toad subepidermal capillary endothelium 
[96].  
  AQP4 is the predominant AQP in the central nervous 
system (CNS) [42]. It is also found at other sites such as  
the basolateral membrane of the collecting duct epithelium, 
with a relatively greater expression in the inner medullary 
collecting duct [97], the basolateral membrane of surface 
epithelial cells in the airways, and salivary gland ductal   
epithelia [94].  
  High-level AQP9 expression has been documented in the 
liver [22, 92], with polarization of the protein to the hepato-
cyte plasma membrane facing the sinusoids [22, 64, 67].  
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2. AQP1 
  AQP1 is selectively and constitutively expressed in the 
CNS, in the apical surface of the choroid plexus (CP) epithe-
lium and, to a lesser extent, in the basolateral membrane and 
endothelia, where it acts both as a water channel and as a 
cGMP-gate ion channel [12, 66]. AQP1 also transports nitric 
oxide across the cell membrane [34]. Its expression in vari-
ous vascular and non-vascular endothelia suggests the hy-
pothesis of its involvement in osmotically-driven transendo-
thelial water movement [98]. In mice, targeted disruption of 
the AQP1 gene induced a decrease in cerebrospinal fluid 
(CSF) production and in intracranial pressure (ICP), indicat-
ing a primary role for it in CSF secretion within the CNS 
[69]. AQP1 levels are low in normal brain capillary endothe-
lial cells [20, 66], and no expression has been detected in 
primary astrocyte cultures from rodents [20].  
  Atrial natriuretic peptide (ANP), a CSF modulator, has 
been implicated in AQP1 channel function regulation. Nota-
bly, activation of the AQP1 cation channel by ANP-activated 
cGMP signaling reduces the net fluid flow from the baso-
lateral to the apical membrane in confluent layers of cultured 
rat CP. The effect is reversed by AQP1 ion channel blockers 
[12].  
  A role for AQP1 as an osmosensor has also been sur-
mised [35], whereby AQP1 would enable the choroid cells to 
sense CSF osmolarity, resulting in transport rate adjust-
ments. Sporadic AQP1 distribution has been described in the 
basolateral membrane and at a much lower level in the apical 
membrane [74]. 
  AQP1 is expressed in brain capillary endothelial cells 
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end-feet [80], suggesting that the latter may signal adjacent 
endothelial cells to switch off its expression.  
  In pathological conditions AQP1 is also expressed else-
where; its upregulation has been documented in cerebral 
vessel endothelia, indicating a role for it in clearing edema 
water from the brain [25]. These data suggest that AQP1 
could be a target for future treatments of various brain condi-
tions, particularly vascular diseases [111]. 
3. AQP4 
  AQP4 is the predominant AQP in the CNS [42], where it 
participates in brain water homeostasis by acting as a key 
constituent of the blood-brain barrier (BBB) and the blood-
CSF barrier [65]. It is expressed in pericapillary astrocyte 
foot processes, external glial limiting membrane, ependyma, 
and subependymal internal glial limiting membrane [65, 76].  
  Marked changes in its levels have been described during 
brain development [102]. In particular, AQP4 up-regulation 
in rat cerebellar glia begins in the second postnatal week 
[109]. mRNA and protein signals increase slightly in the 
course of the first week, rising more than 10-fold during the 
second week (postnatal day [PN] 7-14), and reaching ca. 
60% of adult levels by week 4. The change seems to parallel 
the time course of a reduction in the volume fraction of the 
extracellular space, which starts on PN6-7 and accelerates 
between PN10 and PN21. Its pattern of expression suggests 
that AQP4 may contribute to the development of brain water 
homeostasis and that it may begin to exert its effects from 
the second week of postnatal life [102]. 
  Moreover, the presence of AQP4 in the end-foot mem-
brane has been shown to depend on the presence of proteins 
in the basal lamina such as agrin, -dystroglycan, and 
laminin [31, 99], suggesting that AQP4 is implicated in the 
ability of astrocytes to preserve BBB integrity. In the intra-
cellular region, AQP4 is anchored to several proteins of the 
astrocyte cytoskeleton, such as 1-syntrophin and dystrophin 
[3, 26, 62, 93].  
  The role of AQP4 has been studied using various mouse 
models, including the dystrophin-null mdx-geo transgenic 
mouse, the -syntrophin-null [2, 26, 93], and the AQP4 
knock-out mouse. Deletion of one of the dystroglycan com-
plex proteins, -syntrophin, results in failure of AQP4 colo-
calization in the plasma membrane without alteration of 
overall AQP4 protein expression [62]. In mdx and syntro-
phin knock-out mice, astrocyte swelling may be caused by 
defective water elimination due to impaired AQP4 organiza-
tion at the plasma membrane [7]. AQP4 knock-out mice pro-
vide strong evidence for the involvement of AQP4 in brain 
water balance in the various types of edema [11, 72, 90, 95, 
110]. Although AQP4-deficient mice show no obvious neu-
rological abnormalities, they show considerably reduced 
brain swelling following the induction of cytotoxic edema 
after acute ischemic stroke, water intoxication and bacterial 
infection, indicating that AQP4 has a protective role against 
the development of brain edema [54, 71]. Primary astrocyte 
cultures from AQP4 knock-out mice exhibit greatly reduced 
osmotic water permeability compared with wild-type mice 
[88]. An additional indication of the function of perivascular 
AQP4 was obtained by platelet-derived growth factor B 
(PDGF-B) knock-out mice, which showed abnormal vascular 
morphogenesis resulting in the absence of pericytes, and 
presence of endothelial hyperplasia [33]. 
  In biomolecular studies conducted to gain insights into 
transduction signaling pathways astrocyte end-foot AQP4 
inactivation was evaluated via protein kinase (PKC) phos-
phorylation [4] using two potent PKC activators: phorbol 12 
13 dybutirate (PD) and phorbol 12 myristate 13 acetate 
(PMA). The Authors found that intrathecal application of 
PMA reduced water content and sodium, lending support to 
the notion that astrocytic end-feet provide the pathway for 
sodium and obligatory water in the edematous process. In 
another biomolecular study the 21–nucleotide small interfer-
ing RNA duplex (siRNA) was used to suppress AQP4 ex-
pression in primary astrocyte cultures. AQP4 knock-out re-
sulted in impaired cell growth, altered cell morphology, and 
drastically reduced membrane water permeability. Gene ex-
pression profiles were analyzed by DNA microarray experi-
ments to identify gene expression patterns perturbed by 
AQP4 gene silencing. Gene silencing induced upregulation 
of NGF-B and c-fos, both members of the immediate early 
gene family encoding transcription factors, also induced by 
ischemia [49]. Interestingly, three genes (GLUT1, 
hexokinase, and metallothionein-1) that were downregulated 
as a consequence of AQP4 gene silencing have been demon-
strated to be directly involved in brain ischemia [63].  
  Moreover, enhanced AQP4 expression is found in reac-
tive astrocytes in cerebral infarction ischemic lesions, sug-
gesting a compensatory upregulation of AQP4 to counter the 
water imbalance [5, 6]. 
4. AQP7 
  Data on AQP7 expression in the brain are scanty; the few 
recent findings regard its expression in perinatal mouse brain 
development. Shin and co-workers [83] demonstrated AQP7 
immunoreactivity in CP throughout brain development and 
in ependyma, pia and blood vessels during postnatal brain 
development, surmising its involvement in CSF production. 
5. AQP9 
  AQP9 expression has been documented in glial cells, 
particularly tanycytes and astrocytes [8, 9, 22], endothelial 
cells of subpial vessels [9], and neurons [9, 18], but its func-
tional role in the nervous system is just beginning to be ex-
plored. AQP9 is found in astrocytes, where its expression is 
upregulated after ischemia [8].  
6. AQUAPORINS AND STROKE  
  The presence of AQP4 at the brain-fluid interface sug-
gests that it is important for the brain water balance and may 
play a critical role in edema [61].  
  Stroke and vascular brain disease are generally due to 
cerebral vessel occlusion. The interruption of flow in a brain 
vessel initiates a chain of events involving cytotoxic edema 
with cell swelling, followed by BBB leakage and hemor-
rhagic conversion of tissue [86]. The therapeutic manage-
ment of edema in stroke is currently limited to hyperosmolar 
solutions, to reduce brain water content, and decompression 
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  Recently, the discovery of AQPs has generated new hy-
potheses to explain the molecular mechanisms of edema and 
water transport in the brain [1].  
  AQP expression (AQP3, AQP5 and AQP8) was detected 
by Yamamoto and colleagues [106] in neurons and oli-
godendrocytes, but not in microglia. In an in vitro model of 
hypoxia they demonstrated that expression of AQP4, AQP5 
and AQP9, but not of AQP3 and AQP8, was decreased in 
cultured CNS astrocytes. AQP5 expression was unique in 
showing a transient up-regulation and subsequent down-
regulation after re-oxygenation following hypoxia, whereas 
both AQP4 and AQP9 recovered albeit to no higher than 
control levels. The water permeability of AQP4 has been 
seen to be greater than that of AQP5 [108]. AQP4 knock-out 
mice display reduced cerebral edema in response to water 
intoxication and stroke and improved clinical indices of sur-
vival and neurological status [53]. These data outline a large 
role for AQP4 in brain edema; they also suggest that another 
AQP, one that is hypoxia-responsive (AQP5 or AQP9) 
and/or non-responsive (AQP3 or AQP8), may affect the rate 
of progression of edema due to ischemia or other brain in-
jury. 
  Stroke is divided into hemorrhagic and ischemic. The 
former is characterized by a hydrostatic effect due to intrac-
erebral hemorrhage, followed by formation of perifocal 
edema. Edema is sustained by the release of clot-derived 
proteins and vasoactive substances with direct and indirect 
actions on BBB integrity [105]. As shown in animal models, 
injection of blood into the brain induces edema formation 
through the activation of thrombin, plasminogen activator 
and urokinase [58], leading to inflammatory cell activation, 
BBB impairment and eventually scar formation. BBB dis-
ruption causes vasogenic edema. After the first 10-20 days 
the inflammatory mechanisms activated by BBB dysfunction 
induce CNS cell disruption and red blood cells lysis, with 
release of hemoglobin and its derivatives. These substances 
compound the cell damage, with secondary cellular injury 
that gives rise to cytotoxic edema [28]. Subsequently, the 
production of interleukin, metalloproteinases and other deg-
radation products maintains and contributes to both cytotoxic 
and vasogenic edema, which last 2-3 weeks [79]. Hyperos-
molar solutions are the only therapeutic option for edema in 
intracerebral hemorrhage, even though their effects in pre-
venting mortality and morbidity are not universally acknowl-
edged. The scope for using AQPs as possible therapeutic 
targets to reduce edema in cerebral hemorrhage thus de-
serves extensive investigation.  
  Ischemic stroke is usually due to the occlusion of a cere-
bral artery by a thrombus. This event induces various cell 
modifications, including cell swelling due to cytotoxic 
edema, BBB disruption with vasogenic edema, and finally 
conversion of ischemic into hemorrhagic tissue. The BBB 
dysfunction is related to impaired Na/K ATPase function 
resulting in reduced ATP synthesis and intracellular sodium 
accumulation. Lactate levels rise in response to cellular 
ischemia. Together, lactate and sodium induce a water gradi-
ent toward the intracellular space, with formation of cyto-
toxic edema. The BBB disruption has been hypothesized   
to be related to mechanisms such as reverse pinocytosis   
[15] and calcium modulation signaling [14]. The role of 
AQPs has also been explored in animal models of ischemic 
stroke to gain insights into the pathophysiology of cerebral 
edema. 




- cotransporter, suggested that AQP4 expression 
is initially induced by changes in the metabolic environment, 
and that its upregulation is related to compensation of the 
osmolarity gradient by water transport into the brain. Con-
tinued AQP4 expression even after BBB disruption may ex-
acerbate subsequent brain edema, as suggested by another 
study demonstrating that development of brain edema was 
greatly attenuated in AQP4 knock-out mice [54].  
  The expression profiles of AQP4 and AQP9 in edema 
were recently studied at various time points after mouse   
transient cerebral ischemia to gain insights into their role. 
Two peaks of AQP4 expression were observed 1h and 48h 
post stroke, coinciding with the two peaks of hemispheric 
swelling [18]. This time course was at variance with brain 
trauma data, where AQP4 levels decreased in the first 48h 
then rise again [43-45]. The discrepancy suggests that AQP4 
has a complex role in edema formation and resolution.   
Unlike AQP4, AQP9 showed a gradual and significant   
induction at 24h, with no correlation to swelling, suggesting 
that AQP4, but not AQP9, plays a role in edema formation 
after transient cerebral ischemia in mice. Interestingly, AQP4 
expression was rapidly regulated with a major induction   
1h after stroke in astrocyte end-feet, indicating that early 
time points after the onset of the brain disorder should be 
considered [18].  
  A recent investigation of AQP4 modulation after 3h mid-
dle cerebral artery (MCA) occlusion and 30 min reperfusion 
in rat demonstrated peak AQP4 expression at 72h, suggest-
ing that delayed upregulation could play a significant role in 
brain water clearance after ischemic edema. Friedman and 
co-workers applied 1 to 8h of MCA occlusion followed by 
30 min reperfusion and documented a rapid, spatially selec-
tive loss of AQP4 immunoreactivity in regions subjected to 
sufficiently severe ischemic injury [25].  
  The experimental data on AQP4 regulation from mouse 
stroke models are contradictory; some studies reporting sig-
nificant upregulation after 30 min MCA occlusion and 1-48 
h reperfusion [78] and others describing a decrease in AQP4 
immunoreactivity following longer MCA occlusion, indicat-
ing that its loss post stroke may require a critical duration or 
severity of ischemic injury.  
7. AQPS AND THE CHOROID PLEXUS 
  CSF fluid provides physical support for the brain and a 
specialized extracellular environment facilitating the trans-
port of nutrients, peptides, and hormones to the brain [41]. 
CSF is held to form predominantly in the cerebral ventricles; 
other potential sites include CP, brain parenchyma, and the 
ependymal lining of the ventricles [16, 59]. CSF produced by 
CP epithelial cells (the majority) and by extrachoroidal tis-
sues flows through the ventricles to sites of drainage in the 
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  The CSF secretion mechanisms are well described in the 
adult, whereas much less is known about early CP develop-
ment. Secretion may start with CP formation. In the rat the 
lateral ventricular CP arises around embryonic day (E) 14 
[21, 41]; AQP1 is found in CP epithelial cells from E15 with 
an adult pattern [41], strongly suggesting the beginning of 
CSF formation at this time.  
  Finely regulated CSF composition is vital for the brain 
[38, 39, 77]. Aging- or disease-induced changes in its circu-
lation adversely affect neuron performance [77, 84]. Multiple 
conditions, e.g. tumours, infections, trauma, ischemia and 
hydrocephalus, may influence CP-CSF dynamics [24, 40, 48, 
73, 101]. 
  Hydrocephalus is the result of an imbalance between 
CSF production and resorption that induces an expansion of 
the ventricular system and increased ICP [91]. It is usually 
caused by obstruction to CSF flow in the ventricular system 
or subarachnoid space [55] The increased ICP drives flow 
from the ventricles to the parenchyma, leading to extracellu-
lar edema, especially in subventricular white matter [103].  
  AQP channels, which facilitate water diffusion across the 
blood-CSF interface [12, 89], appear in developing CP epi-
thelia [29, 41] and are retained throughout life. AQP1 is 
heavily expressed at the ventricular-facing membrane of CP 
epithelia [47, 104] but not in BBB endothelium. Water 
movement from blood to cerebral ventricles may thus be 
selectively modulated by regulatory phosphorylation or 
ubiquitination of AQP1 [32, 46]. 
  AQP1 null mice show a 25% reduction in the rate of CSF 
secretion, reduced osmotic permeability of CP epithelia, and 
decreased ICP [69]. 
  A recent study has also documented that AQP4 is 
upregulated in periventricular white matter of hydrocephalic 
rats, and that upregulation increases with disease severity, 
supporting the existence of an adaptive response aimed at 
clearing excess fluid [91]. 
  Obstructive hydrocephalus, produced by kaolin injection 
into the cisterna magna, induced faster ventricular enlarge-
ment in AQP4 knock-out than in wild-type mice [11]. The 
diminished water permeability of ependymal layer, subepen-
dymal astrocytes, astrocytic foot processes and glia limitans 
produced by AQP4 deletion reduces CSF elimination 
through these routes. 
  All these findings support a role for AQP1 in facilitating 
CP secretion of CSF into the cerebral ventricles, and support 
the hypothesis of a role for AQP1 inhibitors in treating hy-
drocephalus and benign intracranial hypertension, which are 
associated with CFS formation or accumulation [61]. Theo-
retically, the same goal could be achieved by enhancing the 
elimination rate of CSF by up-regulating astrocytic expres-
sion of AQP4 [60]. 
  Significantly for CSF dynamics, AQP1 expression is 
diminished in late life. Thus, 20-month-old Sprague-Dawley 
rats display substantially reduced AQP1 expression in CPE 
than their young adult counterparts [57]. Accordingly, CSF 
formation is less abundant in senescent rats [75]. Human CP 
epithelium expresses AQP1 [52]. This raises the possibility 
of treatments that upregulate or restore AQP1 expression in 
aged humans, whose CFS turnover is damaged by Alz-
heimer’s disease or normal pressure hydrocephalus [84, 85], 
by applying an opposite therapy to the one used to manage 
hydrocephalus. 
  MRI techniques affording better resolution now allow 
diffuse villous hyperplasia of the CP to be clinically recog-
nized as a potential, though rare, source of non-obstructive 
hydrocephalus [13, 27, 36].  
8. AQP1 AND TUMOURS 
  An additional role of AQPs connected to their water-
transporting function is related to cell migration [97]. AQP1 
is expressed in tumour microvessels [23], where it seems to 
contribute to increased BBB water permeability in aggres-
sive brain tumours [70]. 
  The involvement of AQPs in cell migration was uncov-
ered based on the observation that tumour angiogenesis was 
impaired in AQP1-null mice and upon subsequent charac-
terization of endothelial cell cultures from wild-type and 
AQP1-null mice [82]. Verkman and co-workers [97] pro-
posed a mechanism of AQP-facilitated cell migration 
whereby actin cleavage and ion uptake at the tip of the 
lamellipodium create local osmotic gradients that drive water 
influx, facilitating lamellipodial extension and cell migra-
tion. AQP-facilitated cell migration was also detected in tu-
mour cells [37], suggesting that it may have an important 
role in tumour angiogenesis and spread, and accounting for 
AQP expression in many tumour cell types and for correla-
tions found between AQP expression and tumour stage in 
some tumours [97].  
  AQP regulation in human CNS tumours has extensively 
been studied, usually on limited numbers of samples. Endo 
and colleagues [23] demonstrated AQP1 immunoreactivity 
in glioma cell lines implanted in rodents. Differential gene 
expression analysis identified AQP1 upregulation in four 
cases of primary human glioblastoma multiforme [56]. 
Saadoun and co-workers [80] confirmed AQP1 up-regulation 
in high-grade astrocytomas using immunohistochemical 
techniques. AQP4 also seems to be up-regulated in glioblas-
toma [81]. AQP4 over-expression in human astrocytoma 
correlates with detection of brain edema on MRI [81, 100].  
  Oshio and colleagues [68] documented intense AQP1 
upregulation in 36 human glial tumours using RT-PCR, 
Western blotting and immunohistochemistry and demon-
strated that AQP1 localization was primarily or exclusively 
to the membrane of neoplastic astrocytes. The exact mecha-
nism of its up-regulation in cells that do not normally ex-
press it is unknown; possible mechanisms include dediffer-
entiation and loss of cell type-specific transcriptional regula-
tion. The involvement of AQPs in transmembrane water 
transport and their up-regulation in neoplastic glial mem-
branes suggest a potential role for them in the formation of 
tumour associated edema [68].  
  CP papilloma and carcinoma are rare brain neoplasms 
often associated with obstruction of CSF ventricular path-
ways and rarely with communicating hydrocephalus due to 
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show different patterns of AQP1 expression [50]. Villous 
hypertrophy of CP is also associated with overproductive 
hydrocephalus. In particular, AQP1 expression is strongly 
though not uniformly increased in some benign papilloma 
lesions with a preserved morphological structure, predicting 
CSF hypersecretion, while complete loss of the papillary 
architecture in CP carcinoma entails a lack of AQP1 expres-
sion, which is associated with normal ventricular size or with 
obstructive hydrocephalus. Thus, preservation of tight junc-
tions and persistent expression of proteins associated with 
specialized features, e.g. AQP1, readily differentiate papil-
loma from carcinoma, possibly explaining why the latter is 
not associated with hypersecreting hydrocephalus [50]. 
  AQP1 expression was analyzed in 10 surgical specimens 
of hemangioma of the CNS, which becomes clinically appar-
ent through the development of huge cysts. Stromal cancer 
cells displayed high AQP1 expression, while large cyst vol-
ume correlated with higher immunostaining scores [51]. 
CONCLUSION 
  AQPs are a rapidly growing and promising field of re-
search. A broad spectrum of specialized functions is ex-
pected to be found for these channels in the CNS. The dis-
covery of selective pharmacological agents for AQPs is a 
stimulating challenge, especially given the lack of treatments 
aimed at this family of channels, and the direct and funda-
mental roles subserved by water channels such as AQP1 and 
AQP4 in brain fluid homeostasis. AQP4 inhibitors seem to 
have a neuroprotective effect in cytotoxic edema, while 
AQP4 activators or upregulators may help clear vasogenic 
and hydrocephalic edema. AQP inhibitors in tumour cells 
and microvessels are predicted to reduce angiogenesis and 
thus tumour spread, offering adjunctive chemotherapy.  
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